Mojia Biotech Completes $80M Series B Financing

Mojia Biotech Completes $80M Series B Financing







Mojia BiotechThe Series B funding for a bio-manufacturing firm based in Shanghai, China, was $80M.

Temasek led the round with participation from LYZZ Capital and Sento Investment. Bits x Bites and Asia Green Fund also participated.

The company intends to use the funds to commercialize its Viridimin™ brand of animal-feed additives, scale up manufacturing capacity for Aliphane™ series of bio-based materials, advance its product pipeline and expand its global R&D capabilities.  

Mojia Biotech, headed by Ansen Chyew is a product-oriented bio-manufacturing firm that produces chemical materials and food ingredients using renewable carbon resources and green processes. In the past few years, the company has developed innovative pathways to produce Viridimin™ brand of Vitamin B5. Aliphane is Mojia Biotech’s second product. a range of biopolymer products that are extremely versatile and have great potential for adhesive and coating applications. 

FinSMEs

24/06/2022






Avatar of Sharma Sahab

Mera naam Sharma hai aur mujhe likhna kafi pasand hai. Jo bhi nya update entertainment, gaming, tech, etc ke related aata hai, mai use yahan cover karta hu.

Leave a Reply

Your email address will not be published.